We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

By LabMedica International staff writers
Posted on 29 Sep 2023
Print article
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) on October 7-8, 2023, at the Grand Hyatt Hotel in Dubai, UAE. At AACC Middle East 2023, attendees will have the chance to engage with industry leaders, healthcare experts, and academics in the field of clinical pathology and laboratory medicine. The exhibit area will attract over 1,000 attendees and feature leading companies in the In Vitro Diagnostics (IVD) sector.

The two-day conference will focus on emerging topics particularly relevant to the Middle East region, while the exposition will showcase the most recent advancements in various aspects such as mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care technologies, and automation. The conference agenda includes educational programs and a dynamic exposition, featuring the newest trends in clinical lab medicine, diagnostics, and best practices from experts. Topics to be discussed range from infectious diseases and big data analytics to prenatal emerging technologies, along with core laboratory practices like sample transportation, lab management, and quality assurance. Each session will feature knowledgeable speakers from AACC's scientific leadership. The event offers a unique opportunity for attendees to network with peers and experts, both from the United States and the Middle East, to exchange insights on the latest in laboratory medicine.

AACC Middle East is tailored for a diverse audience including physicians, lab supervisors, lab directors and their assistants, lab managers, medical technologists, pathologists, immunologists, fellows, residents, and those in training, among other healthcare professionals with an interest in laboratory medicine. Participants will have the chance to explore the latest research and technologies in the field. They can also gain insights into effective lab management strategies to streamline workflows, improve testing accuracy, and subsequently enhance treatment decisions and patient outcomes. Moreover, attendees will also learn how to adopt modern lab testing methods and technology, along with data-driven practices for preanalytical, analytical, and postanalytical phases of sample processing.

Related Links:
ADLM 
Life Dx 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.